Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Innate Pharma S.A. IPHA

Set alert

Price alert · IPHA

All alert types
1.32 USD -0.08 -5.71%

As of Nov 3, 1:08 PM ET

Bid
1.33 × 1
Ask
1.35 × 1
1.32 Day range 1.35
1.17 52-week range 2.71
YTD
-24.57%
1 year
-30.53%
Open
1.35
Prev close
1.40
Mkt cap
149.68M
Vol
67.08K
Avg vol
159.13K
EPS
-0.59
P/E
0.00
Div yield
0.00%
More statistics
Low
1.32
High
1.35
Forward P/E
4.67
Beta
0.87
Short ratio
5.63
Inst. own
0.50%
Dividend
0.00
Ex-div date
Earnings
Mar 21, 2024
50-d avg
1.82
200-d avg
2.23
1y target
7.41

30m chart

Chart tools
Interval
1m5m15m30m

Built from the cached five-day intraday bars.

Signals (11)
NameTimeAgo
MACD: Sell SignalNov 3, 10:00 AM3 hours ago
SMA: BullishNov 2, 3:25 PM22 hours ago
MACD: Buy SignalNov 2, 3:25 PM22 hours ago
RSI: OversoldNov 2, 1:55 PM23 hours ago
MACD: Sell SignalNov 2, 10:25 AM1 day ago
SMA: BearishNov 2, 9:55 AM1 day ago
RSI: OversoldNov 2, 9:55 AM1 day ago
MACD: Buy SignalOct 30, 2:30 PM4 days ago
RSI: OversoldOct 30, 12:30 PM4 days ago
SMA: BearishOct 29, 3:55 PM4 days ago
SMA: BearishOct 29, 9:55 AM5 days ago

Financial health

Altman Z-Score

-22.77 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

4 / 9 Average

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C2 / 5 overall

  • DCF 1
  • Return on Equity 5
  • Return on Assets 1
  • Debt / Equity 1
  • P/E 1
  • P/B 1

Valuation

P/E -2.8×
FY 2016: 25.0×FY 2017: -5.7×FY 2018: 102×FY 2019: -18.5×FY 2020: -319×FY 2021: -7.0×FY 2022: -4.8×FY 2023: -28.1×FY 2024: -2.9×FY 2025: -2.8×
FY 2016 5y median -4.8× FY 2025
P/S 47.8×
FY 2016: 5.5×FY 2017: 8.4×FY 2018: 3.9×FY 2019: 5.6×FY 2020: 3.8×FY 2021: 26.3×FY 2022: 4.8×FY 2023: 4.1×FY 2024: 11.4×FY 2025: 47.8×
FY 2016 5y median 11.4× FY 2025
P/B -6.1×
FY 2016: 3.6×FY 2017: 3.2×FY 2018: 1.9×FY 2019: 1.8×FY 2020: 1.7×FY 2021: 3.0×FY 2022: 5.1×FY 2023: 4.1×FY 2024: 16.3×FY 2025: -6.1×
FY 2016 5y median 4.1× FY 2025
P/FCF -3.8×
FY 2016: -6.7×FY 2017: -5.1×FY 2018: -9.1×FY 2019: -12.6×FY 2020: -4.2×FY 2021: -5.3×FY 2022: -13.7×FY 2023: -6.1×FY 2024: -19.8×FY 2025: -3.8×
FY 2016 5y median -6.1× FY 2025
EV/EBITDA -2.9×
FY 2016: 12.8×FY 2017: -5.1×FY 2018: 12.9×FY 2019: 11.1×FY 2020: 2.5×FY 2021: -6.0×FY 2022: -19.2×FY 2023: -99.2×FY 2024: -2.3×FY 2025: -2.9×
FY 2016 5y median -6.0× FY 2025
EV/Sales 45.8×
FY 2016: 2.5×FY 2017: 5.5×FY 2018: 2.0×FY 2019: 2.9×FY 2020: 2.1×FY 2021: 21.4×FY 2022: 4.1×FY 2023: 3.5×FY 2024: 8.6×FY 2025: 45.8×
FY 2016 5y median 8.6× FY 2025
FCF Yield -26.2%
FY 2016: -14.9%FY 2017: -19.7%FY 2018: -11.0%FY 2019: -7.9%FY 2020: -23.9%FY 2021: -18.7%FY 2022: -7.3%FY 2023: -16.4%FY 2024: -5.1%FY 2025: -26.2%
FY 2016 5y median -16.4% FY 2025

Profitability

Gross Margin 100.0%
FY 2016: 13.4%FY 2017: -105.3%FY 2018: 12.9%FY 2019: 34.5%FY 2020: 28.8%FY 2021: -184.1%FY 2022: 10.4%FY 2023: 10.8%FY 2024: 100.0%FY 2025: 100.0%
FY 2016 5y median 10.8% FY 2025
Operating Margin -1916.9%
FY 2016: 13.5%FY 2017: -122.5%FY 2018: 6.4%FY 2019: -39.2%FY 2020: 1.5%FY 2021: -394.9%FY 2022: -99.6%FY 2023: -24.4%FY 2024: -408.6%FY 2025: -1916.9%
FY 2016 5y median -394.9% FY 2025
Net Margin -1764.5%
FY 2016: 22.5%FY 2017: -148.3%FY 2018: 3.8%FY 2019: -30.1%FY 2020: -91.7%FY 2021: -436.0%FY 2022: -100.7%FY 2023: -14.6%FY 2024: -392.0%FY 2025: -1764.5%
FY 2016 5y median -392.0% FY 2025
ROE 226.7%
FY 2016: 14.7%FY 2017: -56.3%FY 2018: 1.8%FY 2019: -9.5%FY 2020: -41.0%FY 2021: -49.2%FY 2022: -107.3%FY 2023: -14.6%FY 2024: -560.0%FY 2025: 226.7%
FY 2016 5y median -49.2% FY 2025
ROIC -153.3%
FY 2016: 3.6%FY 2017: -21.9%FY 2018: 2.0%FY 2019: -9.6%FY 2020: 0.4%FY 2021: -21.9%FY 2022: -34.1%FY 2023: -8.8%FY 2024: -59.4%FY 2025: -153.3%
FY 2016 5y median -34.1% FY 2025
ROA -78.4%
FY 2016: 4.5%FY 2017: -19.0%FY 2018: 0.7%FY 2019: -5.2%FY 2020: -20.8%FY 2021: -19.7%FY 2022: -28.0%FY 2023: -4.3%FY 2024: -44.5%FY 2025: -78.4%
FY 2016 5y median -28.0% FY 2025

Growth (YoY)

Revenue -77.9%
FY 2016: 213.6%FY 2017: -41.9%FY 2018: 144.8%FY 2019: -13.7%FY 2020: 1.2%FY 2021: -82.6%FY 2022: 376.2%FY 2023: -10.0%FY 2024: -75.7%FY 2025: -77.9%
FY 2016 FY 2025
Operating Income -3.6%
FY 2016: 170.3%FY 2017: -628.1%FY 2018: 112.9%FY 2019: -625.7%FY 2020: 104.0%FY 2021: -4532.3%FY 2022: -20.1%FY 2023: 77.9%FY 2024: -307.1%FY 2025: -3.6%
FY 2016 FY 2025
EPS (diluted) 13.1%
FY 2016: 276.9%FY 2017: -487.0%FY 2018: 105.8%FY 2019: -697.3%FY 2020: 96.6%FY 2021: -5328.6%FY 2022: -28.1%FY 2023: 87.7%FY 2024: -577.8%FY 2025: 13.1%
FY 2016 FY 2025
Free Cash Flow -379.1%
FY 2016: -123.1%FY 2017: -17.0%FY 2018: 37.2%FY 2019: 10.3%FY 2020: -107.0%FY 2021: 5.2%FY 2022: 66.1%FY 2023: -72.2%FY 2024: 79.1%FY 2025: -379.1%
FY 2016 FY 2025

Financial Health

Current Ratio 1.3×
FY 2016: 3.0×FY 2017: 1.9×FY 2018: 1.6×FY 2019: 2.0×FY 2020: 3.8×FY 2021: 1.7×FY 2022: 3.4×FY 2023: 3.7×FY 2024: 2.6×FY 2025: 1.3×
FY 2016 5y median 2.6× FY 2025
Quick Ratio 1.3×
FY 2016: 3.0×FY 2017: 1.8×FY 2018: 1.6×FY 2019: 1.9×FY 2020: 3.7×FY 2021: 1.7×FY 2022: 3.4×FY 2023: 3.7×FY 2024: 2.6×FY 2025: 1.3×
FY 2016 5y median 2.6× FY 2025
Debt / Equity -1.0×
FY 2016: 0.1×FY 2017: 0.1×FY 2018: 0.0×FY 2019: 0.1×FY 2020: 0.1×FY 2021: 0.4×FY 2022: 0.8×FY 2023: 0.8×FY 2024: 3.5×FY 2025: -1.0×
FY 2016 5y median 0.8× FY 2025
Net Debt / EBITDA 0.1×
FY 2016: -15.7×FY 2017: 2.6×FY 2018: -11.8×FY 2019: -10.2×FY 2020: -2.0×FY 2021: 1.4×FY 2022: 3.4×FY 2023: 16.7×FY 2024: 0.8×FY 2025: 0.1×
FY 2016 5y median 1.4× FY 2025
Interest Coverage -121×
FY 2016: 61.1×FY 2017: -354×FY 2018: 50.5×FY 2019: -118×FY 2020: 3.2×FY 2021: -153×FY 2022: -199×FY 2023: -19.8×FY 2024: -91.1×FY 2025: -121×
FY 2016 5y median -121× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31